136 related articles for article (PubMed ID: 10699285)
21. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence.
Florence AT; Hillery AM; Hussain N; Jani PU
J Drug Target; 1995; 3(1):65-70. PubMed ID: 7655823
[TBL] [Abstract][Full Text] [Related]
22. Cell uptake and oral absorption of titanium dioxide nanoparticles.
Janer G; Mas del Molino E; Fernández-Rosas E; Fernández A; Vázquez-Campos S
Toxicol Lett; 2014 Jul; 228(2):103-10. PubMed ID: 24793716
[TBL] [Abstract][Full Text] [Related]
23. Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration.
Tomizawa H; Aramaki Y; Fujii Y; Hara T; Suzuki N; Yachi K; Kikuchi H; Tsuchiya S
Pharm Res; 1993 Apr; 10(4):549-52. PubMed ID: 8483837
[TBL] [Abstract][Full Text] [Related]
24. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats.
Jani P; Halbert GW; Langridge J; Florence AT
J Pharm Pharmacol; 1989 Dec; 41(12):809-12. PubMed ID: 2576440
[TBL] [Abstract][Full Text] [Related]
25. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
van der Lubben IM; Verhoef JC; van Aelst AC; Borchard G; Junginger HE
Biomaterials; 2001 Apr; 22(7):687-94. PubMed ID: 11246962
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
Desai MP; Labhasetwar V; Amidon GL; Levy RJ
Pharm Res; 1996 Dec; 13(12):1838-45. PubMed ID: 8987081
[TBL] [Abstract][Full Text] [Related]
27. Targeting to intestinal M cells.
Jepson MA; Clark MA; Foster N; Mason CM; Bennett MK; Simmons NL; Hirst BH
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):507-16. PubMed ID: 8982824
[TBL] [Abstract][Full Text] [Related]
28. Microparticulate polyelectrolyte complexes for gentamicin transport across intestinal epithelia.
Iannuccelli V; Montanari M; Bertelli D; Pellati F; Coppi G
Drug Deliv; 2011 Jan; 18(1):26-37. PubMed ID: 20726809
[TBL] [Abstract][Full Text] [Related]
29. Oral Vaccination Through Peyer's Patches: Update on Particle Uptake.
Pais Soares EF; Fernandes Borges OM
Curr Drug Deliv; 2018; 15(3):321-330. PubMed ID: 28847272
[TBL] [Abstract][Full Text] [Related]
30. Intestinal barrier to large particulates in mice.
LeFevre ME; Hancock DC; Joel DD
J Toxicol Environ Health; 1980 Jul; 6(4):691-704. PubMed ID: 7420474
[TBL] [Abstract][Full Text] [Related]
31. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.
Kaminskas LM; Kota J; McLeod VM; Kelly BD; Karellas P; Porter CJ
J Control Release; 2009 Dec; 140(2):108-16. PubMed ID: 19686787
[TBL] [Abstract][Full Text] [Related]
32. Rapid insorption of small particles in the gut.
Sass W; Dreyer HP; Seifert J
Am J Gastroenterol; 1990 Mar; 85(3):255-60. PubMed ID: 2309677
[TBL] [Abstract][Full Text] [Related]
33. The gut-associated lymphoid system of two species of Australian marsupial mice, Antechinus swainsonii and Antechinus stuartii. Distribution, frequency and structure of Peyer's patches and lymphoid follicles in the small and large intestine.
Poskitt DC; Duffey K; Barnett J; Kimpton WG; Muller HK
Aust J Exp Biol Med Sci; 1984 Feb; 62 ( Pt 1)():81-8. PubMed ID: 6743144
[TBL] [Abstract][Full Text] [Related]
34. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
[TBL] [Abstract][Full Text] [Related]
35. Surface engineered nanoliposomal platform for selective lymphatic uptake of asenapine maleate: In vitro and in vivo studies.
Managuli RS; Wang JT; Faruqu FM; Pandey A; Jain S; Al-Jamal KT; Mutalik S
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110620. PubMed ID: 32228915
[TBL] [Abstract][Full Text] [Related]
36. Qualitative investigation of uptake of fine particle size microcrystalline cellulose following oral administration in rats.
Kotkoskie LA; Butt MT; Selinger E; Freeman C; Weiner ML
J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):531-5. PubMed ID: 8982827
[TBL] [Abstract][Full Text] [Related]
37. Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake.
Bachhav SS; Dighe VD; Kotak D; Devarajan PV
Int J Pharm; 2017 Oct; 532(1):612-622. PubMed ID: 28935258
[TBL] [Abstract][Full Text] [Related]
38. Uptake of inert microparticles in normal and immune deficient mice.
Smyth SH; Feldhaus S; Schumacher U; Carr KE
Int J Pharm; 2008 Jan; 346(1-2):109-18. PubMed ID: 17723283
[TBL] [Abstract][Full Text] [Related]
39. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
Shakweh M; Ponchel G; Fattal E
Expert Opin Drug Deliv; 2004 Nov; 1(1):141-63. PubMed ID: 16296726
[TBL] [Abstract][Full Text] [Related]
40. Uptake and transport of foreign particles in Peyer's patches of both distal ileum and jejunum of calves.
Sein Lwin ; Inoshima Y; Ueno H; Ishiguro N
Cell Tissue Res; 2009 Jul; 337(1):125-35. PubMed ID: 19421780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
